Your Health. Your Family. Your Choice.
Life Threatening? No
Write-up: Initial report received on 10 September 2007 from a health care professional. A four-month-old infant with no concurrent illnesses, no known allergies, and who had no pre-existing medical history, had received a second intramuscular dose of ActHib, lot number UF160AA (Sanofi Pasteur SA lot number A0122-2) in the left thigh; a second intramuscular dose of Daptacel, lot number C2650AA in the right thigh; a second intramuscular dose of IPOL, lot number Z0872-2 (reported as Z0872), in the right thigh; and a second intramuscular dose of Prevnar (manufacturer Wyeth), lot number B97283B, in the left thigh. The patient had not experienced any adverse events following prior vaccinations. Later that evening the patient was "found expired." Reportedly, an autopsy will be completed. 3/19/08 Reviewed autopsy report which states COD as complications of congenital pulmonary malformation. 3/19/08 Autopsy states pathologic diagnoses as: I. Congenital Pulmonary malformation with A. Microscopic characteristics most c/w congenital cystic adenomatoid malformation, Type I B. lymphocytic & macrophage peri-bronchial inflammation, mod to marked C. Intraalveolar hemorrhage, marked D. pulmonary edema, marked III. Abnormal 17 hydroxyprogesterone study w/o microscopic abnormality of adrenal glands.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166